Millions of older Americans could soon pay less for popular GLP-1 weight-loss drugs.

Medicare last week started a pilot program that lets eligible people in some Medicare plans get medications such as Wegovy and Zepbound for about $50 a month. Until now, Medicare generally covered these drugs only for certain medical conditions, such as heart disease or sleep apnea. The new program expands access for many people with obesity and is expected to run through the end of next year.

For people paying hundreds of dollars a month out of pocket, that could be a big change.

In Canada, coverage varies by province and insurance plan. Canadian readers should check with their provincial drug program or private insurer.

GLP-1s can help people lose a lot of weight, as much as 20% when combined with exercise and healthy lifestyle changes. But some of that weight can come from muscle and bone, not just body fat.

That’s why strength training matters.

Lifting weights, using resistance machines, and doing body-weight exercises can help preserve muscle, support bone health, improve balance, and lower the risk of falls. Getting enough protein matters, too.

If you’re thinking about a GLP-1 medication, start with your doctor. And if you take one, make strength training part of the plan. Our coaches can help you build a safe, effective routine that supports weight loss while protecting your strength.